Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

Clinical trial NCT06812104 · RECRUITING

Trial details

NCT number: NCT06812104
Sponsor: Kyowa Kirin Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory AML and Other Hematologic Malignancies

Start date: 2024-10-10
Primary completion: 2031-11-30
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.